During the past decade, CHU Nantes - Hôtel Dieu; Ophthalmology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CHU Nantes - Hôtel Dieu; Ophthalmology" are "Choroideremia" (2 trials), "Cone Rod Dystrophy" (2 trials), "Diabetic Macular Edema" (2 trials), "Retinitis Pigmentosa" (2 trials) and "Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "CHU Nantes - Hôtel Dieu; Ophthalmology" in a lesser frequency.

Most popular intervention types in "CHU Nantes - Hôtel Dieu; Ophthalmology" are "Drug" (5 trials), "Device" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (4 trials), "Sham Procedure" (4 trials), "Aflibercept" (2 trials), "Intelligent Retinal Implant System" (2 trials) and "Lampalizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Nantes - Hôtel Dieu; Ophthalmology" are 8 trials for "All" genders.

Currently, there are NaN active trials in "CHU Nantes - Hôtel Dieu; Ophthalmology". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CHU Nantes - Hôtel Dieu; Ophthalmology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CHU Nantes - Hôtel Dieu; Ophthalmology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".